1492 Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-39,244
| Closed | -$1.18K | – | 128 |
|
|
2025
Q1 | $1.18K | Hold |
39,244
| – | – | ﹤0.01% | 111 |
|
|
2024
Q4 | $9.02K | Hold |
39,244
| – | – | ﹤0.01% | 109 |
|
|
2024
Q3 | $84.4K | Hold |
39,244
| – | – | 0.04% | 99 |
|
|
2024
Q2 | $202K | Buy |
39,244
+17,500
| +80% | +$90.3K | 0.11% | 90 |
|
|
2024
Q1 | $116K | Hold |
21,744
| – | – | 0.06% | 92 |
|
|
2023
Q4 | $169K | Hold |
21,744
| – | – | 0.1% | 97 |
|
|
2023
Q3 | $85.9K | Hold |
21,744
| – | – | 0.06% | 91 |
|
|
2023
Q2 | $68.5K | Hold |
21,744
| – | – | 0.04% | 98 |
|
|
2023
Q1 | $58.1K | Hold |
21,744
| – | – | 0.04% | 100 |
|
|
2022
Q4 | $78.1K | Buy |
+21,744
| New | +$78.1K | 0.05% | 98 |
|